Published in Eur J Histochem on January 01, 1997
Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. Am J Pathol (2002) 1.16
Different apoptotic responses and patterns in adhering and floating neoplastic cell cultures: effects of microtubule antagonists. Histochem Cell Biol (2002) 0.75
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31
Six-year follow-up of the first Waterloo school smoking prevention trial. Am J Public Health (1989) 3.14
A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol (1998) 1.76
Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst (1981) 1.68
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). Int J Biol Markers (2002) 1.40
UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase. J Biol Chem (1998) 1.30
Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation. Aliment Pharmacol Ther (2003) 1.25
Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer (1981) 1.24
Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. Ann Oncol (2011) 1.24
Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. Br J Clin Pharmacol (2006) 1.22
Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer (1985) 1.18
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat (1986) 1.18
A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene (2009) 1.14
Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp Cell Res (2001) 1.11
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. Transfusion (2000) 1.10
The phosphoenolpyruvate carboxylase gene family of Sorghum: promoter structures, amino acid sequences and expression of genes. Gene (1991) 1.07
CD38 functions are regulated through an internalization step. J Immunol (1998) 1.06
The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Exp Cell Res (1992) 1.05
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ (2012) 1.05
Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus. J Histochem Cytochem (1995) 1.04
Targeting of the Akt/PKB kinase to the actin skeleton. Cell Mol Life Sci (2003) 1.03
Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene. Oncogene (1998) 1.02
Altered epigenetic signals in human disease. Cancer Biol Ther (2004) 1.02
Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer (1991) 1.01
Nuclear changes in a case of X-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve (1999) 1.00
Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics. Cancer (1974) 1.00
An application of mixture distributions in modelization of length of hospital stay. Stat Med (2008) 1.00
DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography. Cytometry (1981) 0.99
Clinical studies of Bcl-2 and treatment benefit in breast cancer patients. Endocr Relat Cancer (1999) 0.99
Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. Br J Cancer (2009) 0.99
Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur J Cell Biol (1995) 0.99
Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem Biophys Res Commun (2000) 0.98
High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma. Br J Cancer (2008) 0.98
p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J Pathol (1995) 0.98
Topology of inositol lipid signal transduction in the nucleus. J Cell Physiol (1999) 0.98
Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans. Oncogene (1998) 0.98
Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum Mol Genet (1998) 0.97
Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer (1991) 0.97
Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug. Curr Med Chem (2013) 0.97
Correlation of cell kinetic findings with morphology of non-Hodgkin's malignant lymphomas. J Natl Cancer Inst (1977) 0.96
Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions. Exp Cell Res (1994) 0.95
Correction of congenital hydrocephalus in utero II: Efficacy of in utero shunting. J Pediatr Surg (1984) 0.95
Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients. J Natl Cancer Inst Monogr (1992) 0.94
Development of Fe-deficiency responses in cucumber (Cucumis sativus L.) roots: involvement of plasma membrane H(+)-ATPase activity. J Exp Bot (2000) 0.94
Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells. J Cell Sci (1999) 0.93
Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer. J Natl Cancer Inst Monogr (2001) 0.92
The health status of rural school children in the Amazon basin of Ecuador. J Trop Pediatr (1999) 0.92
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells. Eur J Cancer (2002) 0.92
Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas. Basic Appl Histochem (1986) 0.92
Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer. Int J Cancer (1999) 0.92
Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells. J Cell Biol (1965) 0.92
Analysis of mesenchymal stem cells grown on a three-dimensional HYAFF 11-based prototype ligament scaffold. J Biomed Mater Res A (2005) 0.91
Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clin Cancer Res (2013) 0.91
P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Biol Cell (1999) 0.91
Heterogeneous radiation and heat sensitivity in vitro of human melanoma xenograft lines established from different lesions in the same patient. Comparisons with the radiation and heat sensitivity of cells isolated from the donor patient's surgical specimens. Int J Radiat Biol (1990) 0.90
Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Nephron (1999) 0.90
Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extension. Breast Cancer Res Treat (1997) 0.90
MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas. Cell Prolif (1997) 0.90
In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells. Eur J Cancer (1994) 0.90
Changes in biological markers after primary chemotherapy for breast cancers. Int J Cancer (1995) 0.89
Colocalization prostacyclin (PGI2) synthase--caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp Cell Res (2001) 0.89
Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women. Br J Cancer (2000) 0.89
Control of intestinal helminths in schoolchildren in Low-Napo, Ecuador: impact of a two-year chemotherapy program. Rev Soc Bras Med Trop (2000) 0.89
Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs. Eur J Cancer (1981) 0.89
Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells. Br J Cancer (1998) 0.89
Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol (2001) 0.88
DNA double-strand break repair and radiation response in human tumour primary cultures. Int J Radiat Biol (1994) 0.88
Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients. Ann Oncol (2011) 0.88
Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus (1997) 0.88
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells. Cell Mol Life Sci (2004) 0.88
A fluorescent in situ hybridization method in flow cytometry to detect HIV-1 specific RNA. J Immunol Methods (1996) 0.88
Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1. Cell Mol Life Sci (2003) 0.87
Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer. NCI Monogr (1986) 0.87
Emerin expression at the early stages of myogenic differentiation. Differentiation (2000) 0.87
Intramembrane protein distribution in cell cultures is affected by 50 Hz pulsed magnetic fields. Bioelectromagnetics (1997) 0.87
IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells. Cytometry (1997) 0.87
Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. Eur J Cancer (1994) 0.87
Namitecan: a hydrophilic camptothecin with a promising preclinical profile. Curr Med Chem (2012) 0.86
Synthesis and antiproliferative activity of substituted 3[2-(1H-indol-3-yl)- 1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]pyridines, marine alkaloid nortopsentin analogues. Curr Med Chem (2014) 0.86
Phospholipid rearrangement of apoptotic membrane does not depend on nuclear activity. Histochem Cell Biol (1998) 0.86
A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis. Am J Hum Genet (1999) 0.86
Short-term variation in labeling index as a predictor of radiotherapy response in human oral cavity carcinoma. Int J Radiat Oncol Biol Phys (1984) 0.86
Cefquinome sulfate behavior after intramammary administration in healthy and infected cows. J Dairy Sci (2011) 0.86
Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models. Biochem Pharmacol (2013) 0.86
Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells. Exp Cell Res (1995) 0.86
Interaction of volkensin with HeLa cells: binding, uptake, intracellular localization, degradation and exocytosis. Cell Mol Life Sci (2004) 0.85
Early and late complications among 15 victims exposed to indoor fire and smoke inhalation. Burns (2007) 0.85
Localization of single copy gene by PRINS technique. Nucleic Acids Res (1993) 0.85
Serum free DNA and COX-2 mRNA expression in peripheral blood for lung cancer detection. Thorax (2008) 0.85
Immunoreactivity to MIB-1 in breast cancer: methodological assessment and comparison with other proliferation indices. Cell Prolif (1997) 0.85